In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 6: Hypertension mediated target organ damage and hypertension phenotypes
Session

Event : ESC Congress 2019

Topic : European Society of Cardiology

  • Session type : Poster Session
  • Date : 03 September 2019
  • Time : 10:30 - 14:30

13 presentations in this session

The role of ST2 as an early marker of endothelial dysfunction in hypertensive patients

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : AD Farcas (Cluj Napoca,RO)

Assessment of carotid cross sectional area in hypertensive patients: phenotyping and prognostic validation in the campania salute network

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : C Mancusi (Naples,IT)

Prevalence of left atrial enlargement in patients undergoing an echocardiogram for cardiovascular risk stratification at an esh excellence centre in italy

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : ML Muiesan (Brescia,IT)

Left atrial dysfunction is a potent predictor of ischemic complications in hypertensive patients

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : D Shorikova (Chernivtsy,UA)

Arterial hypertension, right heart remodelling and intrarenal haemodynamics: the mysterious triangle in the cardiovascular continuum

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : I Cabac-Pogorevici (Chisinau,MD)

Hyperfiltration could be a risk factor for development of hypertension: A five-year cohort study

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : M Kuwabara (Tokyo,JP)

Exaggerated exercise blood pressure response is accompanied by increased sympathetic activity and arterial stiffness in subjects with high normal blood pressure

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : T Kalos (Athens,GR)

Gender related differences in the clinical significance of elevated pulse pressure in the young. Results from the HARVEST study.

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : F Saladini (Padova,IT)

Systolic versus diastolic blood pressure as predictors of cardiovascular events among treated hypertensive patients: a 6-year prospective study

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : A Kasiakogias (Athens,GR)

Isolated systolic hypertension and combined systolic-diastolic hypertension for prediction of new-onset diabetes mellitus: Data from a 8-year-follow-up study

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : I Liatakis (Athens,GR)

Studying target organ damage indices in newly diagnosed and never treated extreme dipper patients with essential hypertension

Event : ESC Congress 2019

  • Session : Hypertension mediated target organ damage and hypertension phenotypes
  • Speaker : H Triantafyllidi (Athens,GR)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are